MarketScreener Strategies Zealand Pharma A/S
Equities
ZEAL
DK0060257814
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 369.20 DKK | -0.62% |
|
+2.56% | -20.84% |
| 03:12pm | Zealand Pharma Says Phase 2 Petrelintide Study Met Primary Endpoint of Body Weight Reduction Versus Placebo | MT |
| 02:47pm | Roche, Zealand Pharma Obesity Drug Hits Goal in Midstage Trial | DJ |
MarketScreener Strategies
Search
No results for this search
- Stock Market
- Equities
- ZEAL Stock
- News Zealand Pharma A/S
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition